ScholarMate
English简体中文繁體中文
客服熱線:400-1616-289
登入註冊
期刊論文

Prognostic significance of tumor regression grade in esophageal squamous cell carcinoma after neoadjuvant chemoradiation

Zhang, Chi; Xu, Fei; Qiang, Yong; Cong, Zhuang-Zhuang; Wang, Qin; Zhang, Zheng; Luo, Chao; Qiu, Bing-Mei*; Hu, Li-Wen*; Shen, Yi*南方医科大学; 南京大学; y
Frontiers in Surgery2023-1-6DOI: 10.3389/fsurg.2022.1029575
1被引14閱讀
引用收藏
分享

摘要

BackgroundsTrimodal therapy (neoadjuvant chemoradiotherapy followed by esophagectomy) for locally advanced esophageal squamous cell carcinoma (ESCC) is associated with a significant survival benefit. Modified Ryan score is an effective tool to evaluated the tumor regression grade (TRG) after neoadjuvant therapy. The aim of this study was to evaluate the prognostic value of TRG for overall survival (OS) and disease-free survival (DFS) in ESCC patients undergoing neoadjuvant chemoradiation. MethodsThe study retrospectively reviewed 523 ESCC patients who underwent neoadjuvant chemoradiotherapy and radical esophagectomy at Jinling Hospital from January 2014 to July 2020. Kaplan-Meier curves with log-rank test and Cox regression model were used to evaluate the prognostic factor of TRG based on modified Ryan scoring system on OS and DFS. ResultsAfter application of inclusion and exclusion criteria, 494 patients with ESCC following neoadjuvant chemoradiotherapy and radical esophagectomy were available for analysis. The TRG scores are significantly associated with smoke history (p = 0.02), lymphovascular invasion (LVI) and/or peripheral nerve invasion (PNI) (p < 0.01), and postoperative adjuvant therapy (p < 0.01). Meanwhile, tumor characteristics including tumor length (p < 0.01) and tumor differentiation grade (p < 0.01) are also significantly associated with TRG score. The results of multivariable Cox regression modal showed that TRG is not an independently prognostic factor for OS (p = 0.922) or DFS (p = 0.526) but tumor length is an independently prognostic factor for DFS (p = 0.046). ConclusionsThis study evaluated the prognostic value of modified Ryan scoring system for ESCC after trimodal therapy and concluded that modified Ryan scoring system can predict survival and recurrence rates but is not an independently prognostic factor for OS and DFS.

學科與關鍵詞

關鍵詞
esophageal squamous cell carcinomaneoadjuvant chemoradiotherapyesophagectomytumor regression grademodified ryan scoring system
相關
載入中…

文獻載入失敗,請重試

重試

發表資訊

論文狀態
公開發表
期刊
Frontiers in Surgery
發表日期
2023-01-06
卷期
第 9 卷
頁碼
1029575
DOI
10.3389/fsurg.2022.1029575
成果收錄
SCIE

作者

  • Z

    Zhang, Chi (第一作者)

    nanjing univ

  • X

    Xu, Fei

    nanjing med univ

查看全部 10 位作者收起作者
  • Q

    Qiang, Yong

    southeast univ

  • C

    Cong, Zhuang-Zhuang

    nanjing univ

  • W

    Wang, Qin

    nanjing univ

  • Z

    Zhang, Zheng

    nanjing med univ

  • L

    Luo, Chao

    southern med univ

  • Q

    Qiu, Bing-Mei (通訊)

  • H

    Hu, Li-Wen (通訊)

    nanjing univ

  • S

    Shen, Yi (通訊)

    nanjing med univ · southern med univ · southeast univ · nanjing univ

登入解鎖更多功能

  • 收藏這篇,隨時在「我的 · 收藏」找回
  • 認領你的成果,生成推廣素材
  • 關注作者獲取最新成果
  • 加入項目組、協同寫作
註冊 / 登入

產品服務

  • 科研之友
  • 創新城
  • 科創雲

服務支援

  • 幫助中心
  • 隱私政策
  • 服務條款

聯絡方式

線上客服:【】
客服熱線:400-1616-289
電子郵件:support@scholarmate.com

關注或下載科研之友

微信 QR Code
微信公眾號
客戶端下載 QR Code
下載客戶端
科研成果科研人員科研機構科研動態愛瑞思軟件

©2026 深圳市科研之友网络服务有限公司

公安備案圖示粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417